Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Covalent Bonds01:29

Covalent Bonds

161.6K
Overview
161.6K
Covalent Bonds01:08

Covalent Bonds

10.5K
Overview
When two atoms share electrons to complete their valence shells, they create a covalent bond. An atom's electronegativity—the force with which shared electrons are pulled towards an atom—determines how the electrons are shared. Molecules formed with covalent bonds can be either polar or nonpolar. Atoms with similar electronegativities form nonpolar covalent bonds; the electrons are shared equally. Atoms with different electronegativities share electrons unequally,...
10.5K
Network Covalent Solids02:18

Network Covalent Solids

16.1K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

9.4K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

2.0K
2.0K
Covalent Bonding and Lewis Structures02:46

Covalent Bonding and Lewis Structures

61.2K
Compared to ionic bonds, which results from the transfer of electrons between metallic and nonmetallic atoms, covalent bonds result from the mutual attraction of atoms for a “shared” pair of electrons.
61.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Probing 3-Amino-2H-Azaindazoles as Allosteric Inhibitors of the Protein Tyrosine Phosphatase SHP2.

ChemMedChem·2026
Same author

Mapping Functionally Relevant Tractable Lysines of Challenging Protein Targets by Covalent Fragment Screening.

Chembiochem : a European journal of chemical biology·2026
Same author

Toward a Random Background for Ligand Optimization.

bioRxiv : the preprint server for biology·2026
Same author

Fragment-Based Design of Targeted Covalent Inhibitors: The Scope and Limitation of Linking Approaches.

ChemMedChem·2026
Same author

α-Halothioamide warheads with enhanced cysteine reactivity and specificity for covalent protein labelling.

Nature communications·2026
Same author

Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio B.

International journal of molecular sciences·2026
Same journal

Metal-Drug Complexes as Long-Release Application for Antimalarial PfFNT-Inhibitors.

ChemMedChem·2026
Same journal

Speciation Studies of Monosubstituted Pt, Mo, and W Decavanadates in Culture Media and In Vitro Activity Against Trypanosoma cruzi.

ChemMedChem·2026
Same journal

Novel Xanthene Derivatives for Neuroprotection in Alzheimer's Disease-Synthesis and Biological Assessment.

ChemMedChem·2026
Same journal

Discovery of a New Scaffold RSK2 Inhibitor With Virtual and Phenotypical Screening.

ChemMedChem·2026
Same journal

Levoglucosenone-Derived Isothiocyanates as Antifungal Compounds: Merging Sustainability and Medicinal Chemistry.

ChemMedChem·2026
Same journal

Bacterial Ghosts as Innovative Transport Vehicles for Platinum-Based Anticancer Drugs.

ChemMedChem·2026
See all related articles

Related Experiment Video

Updated: Jan 28, 2026

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

1.2K

DUckCov: a Dynamic Undocking-Based Virtual Screening Protocol for Covalent Binders.

Moira Rachman1,2, Andrea Scarpino2, Dávid Bajusz2

  • 1Facultat de Farmàcia and Institut de Biomedicina, Universitat de Barcelona, Av. Joan XXIII 27-31, 08028, Barcelona, Spain.

Chemmedchem
|February 21, 2019
PubMed
Summary
This summary is machine-generated.

Designing effective covalent drugs requires optimizing noncovalent interactions. This study introduces a new computational protocol combining tethered docking and Dynamic Undocking (DUck) to identify potent covalent inhibitors by prioritizing strong protein binders.

Keywords:
covalent dockingdynamic undockingtargeted covalent inhibitorsvirtual screening

More Related Videos

Synthesis of Information-bearing Peptoids and their Sequence-directed Dynamic Covalent Self-assembly
09:34

Synthesis of Information-bearing Peptoids and their Sequence-directed Dynamic Covalent Self-assembly

Published on: February 6, 2020

7.9K
Emergency Undocking in Robotic Surgery: A Simulation Curriculum
06:48

Emergency Undocking in Robotic Surgery: A Simulation Curriculum

Published on: May 20, 2018

10.1K

Related Experiment Videos

Last Updated: Jan 28, 2026

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

1.2K
Synthesis of Information-bearing Peptoids and their Sequence-directed Dynamic Covalent Self-assembly
09:34

Synthesis of Information-bearing Peptoids and their Sequence-directed Dynamic Covalent Self-assembly

Published on: February 6, 2020

7.9K
Emergency Undocking in Robotic Surgery: A Simulation Curriculum
06:48

Emergency Undocking in Robotic Surgery: A Simulation Curriculum

Published on: May 20, 2018

10.1K

Area of Science:

  • Medicinal Chemistry
  • Computational Drug Discovery
  • Pharmacology

Background:

  • The design of safe and effective covalent drugs is a growing area of interest, driven by recent guidelines.
  • Optimizing the noncovalent binding framework is crucial for enhancing the potency and selectivity of covalent binders.
  • Existing computational tools for predicting covalent binding mechanisms are continually being developed.

Purpose of the Study:

  • To introduce a novel computational protocol for identifying covalent inhibitors.
  • To emphasize the importance of the noncovalent complex in the covalent binding process.
  • To develop a fast, iterative method for exploring chemical space and discovering targeted covalent inhibitors.

Main Methods:

  • A new protocol utilizing tethered and constrained docking in combination with Dynamic Undocking (DUck).
  • The protocol is designed to prioritize strong protein binders.
  • Dedicated covalent docking methods are employed for ranking and selecting virtual hits based on predicted binding modes.

Main Results:

  • The protocol successfully validated on Janus Kinase 3 (JAK3) and KRas targets.
  • Demonstrated the ability to explore a wide chemical space efficiently.
  • Successfully identified potent targeted covalent inhibitors.

Conclusions:

  • The described protocol offers a valuable approach for the rational design of covalent inhibitors.
  • The integration of noncovalent binding optimization with covalent docking enhances inhibitor discovery.
  • This method provides a fast and iterative strategy for identifying novel covalent therapeutics.